Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MONTERO

Showing results (511-520 of 552) with videos related to

Pageof 56
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast CancerNickolas Stabellini, Mantas Dmukauskas, Marcio S Bittencourt, et al.
Breast Cancer Research and Treatment|December 6, 2011
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancerA J Montero, C M Diaz-Montero, Y E Deutsch, et al.
NPJ Breast Cancer|June 25, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancerReine Abou Zeidane, Benjamin Hauk, Samuel Lichtman-Mikol, et al.
JAMA Oncology|November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical TrialVeronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.
European Journal of Ophthalmology|August 2, 2024
A randomised study comparing performance and safety of Eyestil Plus<sup>®</sup> vs Vismed Multi<sup>®</sup> in moderate-to-severe dry eye syndrome patientsP J Pisella, P Gain, B Cochener, et al.
Journal of the American Heart Association|July 9, 2024
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal CancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JCO Oncology Practice|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular RiskNickolas Stabellini, Tarek Nahle, Viraj Shah, et al.
The Journal of Clinical Endocrinology and Metabolism|July 13, 2021
In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate CancerJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.
Cancer|June 7, 2005
The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective studyAlberto J Montero, Roman Rouzier, Ana Lluch, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2025
miR-191-5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesityFrancisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Vicente Herrero-Aguayo, et al.
Pageof 56

Showing results (511-520 of 552) with videos related to

Sort By:
Pageof 56
Journal of the National Comprehensive Cancer Network : JNCCN|July 11, 2023
Social Determinants of Health and Racial Disparities in Cardiac Events in Breast CancerNickolas Stabellini, Mantas Dmukauskas, Marcio S Bittencourt, et al.
Breast Cancer Research and Treatment|December 6, 2011
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancerA J Montero, C M Diaz-Montero, Y E Deutsch, et al.
NPJ Breast Cancer|June 25, 2026
Prognostic consistency of oncotype DX® molecular assay across racial groups in early-stage hormone receptor-positive breast cancerReine Abou Zeidane, Benjamin Hauk, Samuel Lichtman-Mikol, et al.
JAMA Oncology|November 5, 2020
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer: A Randomized Clinical TrialVeronica Mariotti, Hyo Han, Roohi Ismail-Khan, et al.
European Journal of Ophthalmology|August 2, 2024
A randomised study comparing performance and safety of Eyestil Plus<sup>®</sup> vs Vismed Multi<sup>®</sup> in moderate-to-severe dry eye syndrome patientsP J Pisella, P Gain, B Cochener, et al.
Journal of the American Heart Association|July 9, 2024
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal CancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JCO Oncology Practice|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular RiskNickolas Stabellini, Tarek Nahle, Viraj Shah, et al.
The Journal of Clinical Endocrinology and Metabolism|July 13, 2021
In1-Ghrelin Splicing Variant as a Key Element in the Pathophysiological Association Between Obesity and Prostate CancerJuan M Jiménez-Vacas, Antonio J Montero-Hidalgo, Enrique Gómez-Gómez, et al.
Cancer|June 7, 2005
The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective studyAlberto J Montero, Roman Rouzier, Ana Lluch, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2025
miR-191-5p: A tumour suppressor miRNA and a personalized biomarker and potential therapeutic tool connecting prostate cancer and obesityFrancisco Porcel-Pastrana, Antonio J Montero-Hidalgo, Vicente Herrero-Aguayo, et al.
Pageof 56